Livedo reticularis: a side effect of interferon therapy in a pediatric patient with melanoma

Pediatr Dermatol. 2012 May-Jun;29(3):333-5. doi: 10.1111/j.1525-1470.2011.01426.x. Epub 2011 May 16.

Abstract

Livedo reticularis is a lacy mottling of the skin that can have many etiologies. We report a case of an 8-year-old boy with a diagnosis of melanoma who developed persistent livedo reticularis during treatment with interferon alpha-2B. To our knowledge, this is the first case report of livedo reticularis occurring as a side effect of interferon treatment for pediatric melanoma. Given the increasing incidence of pediatric melanoma, it is important that dermatologists be aware of potential side effects of interferon therapy to optimize care and education for these patients.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Child
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Livedo Reticularis / etiology*
  • Livedo Reticularis / pathology
  • Male
  • Melanoma / drug therapy*
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Skin Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins